Thelansis

  Non-cystic fibrosis bronchiectasis is an incurable pulmonary disorder characterised pathologically by permanent bronchial dilatation and severe bronchial inflammation and clinically by chronic productive cough and recurrent infectious exacerbations. They are further characterised by permanent dilatation of the airways leading to persistent cough, sputum production, dyspnoea, and recurrent exacerbations. Current clinical management is typically multifaceted and includes treatment of concurrent etiologic conditions, promotion of airway clearance, reduction in bronchial inflammation, and suppression or prevention of chronic bronchial infection.   ·        In the USA, the incidence of Non-cystic fibrosis bronchiectasis cases ranges between 33 to 79 cases for 100,000 population. The prevalence cases go between 142 to 221 cases per 100,000 persons. ·        Women are more susceptible to this disease; the number of w...